WHO-GMP Certified Commercial Pack · Product Code: AKP-027
Clindamycin 1.0% & Nicotinamide 4.0% Gel
Formulation Overview: Oil-free aqueous anti-acne gel pairing lincosamide bacteriostatic inhibition of Cutibacterium acnes with anti-inflammatory vitamin B3 (nicotinamide) sebum regulation. Formulated with Clindamycin Phosphate USP (eq. 1.0% w/w) + Nicotinamide IP 4.0% w/w (1.0% + 4.0% w/w) in Topical Anti-Acne Gel dosage form under Dermatology & Topicals, manufactured to IP / BP / USP Compendial standards and supplied in 15g / 20g Laminated Squeeze Tube with Carton with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-027 |
|---|---|
| Therapeutic Sector | Dermatology & Topicals |
| Dosage Form | Topical Anti-Acne Gel |
| Active Ingredient | Clindamycin Phosphate USP (eq. 1.0% w/w) + Nicotinamide IP 4.0% w/w |
| Strength / Purity | 1.0% + 4.0% w/w |
| Clinical Indication | Mild-to-moderate inflammatory acne vulgaris (papules and pustules) |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 15g / 20g Laminated Squeeze Tube with Carton |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C; protect from heat and light |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |